NDC properties for "mercaptopurine 100 MG per 5 ML Oral Suspension" (RxCUI 1536484)
About this data
The tables show NDC propoerties for mercaptopurine 100 MG per 5 ML Oral Suspension with the RxCUI 1536484
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for mercaptopurine 100 MG per 5 ML Oral Suspension (RxCUI 1536484)
| ANDA | ANDA216418 |
|---|---|
| MMSL_CODE | BD14208 |
| MMSL_CODE | CD14208 |
| RxCUI | 1536484 |
| SNOMEDCT | 1179429004 |
| SPL_SET_ID | 0a366cf3-91f0-4aa4-8f34-a7a27cad8f15 |
| SPL_SET_ID | 25b39be7-fe1e-efe6-e063-6294a90a6e8d |
| VUID | 4033372 |
| Prescribable Synonym | mercaptopurine 20 MG in 1 mL Oral Suspension |
| RXNAV_STR | mercaptopurine 20 MG/ML Oral Suspension |
| RxNorm Name | mercaptopurine 20 MG/ML Oral Suspension |
| RxNorm Synonym | mercaptopurine 100 MG per 5 ML Oral Suspension |
| RxNorm Synonym | mercaptopurine 20 MG per 1 ML Oral Suspension |
| RxNorm Synonym | mercaptopurine 2000 MG per 100 ML Oral Suspension |
| Related queries | Interactions (for RxCUI 1536484) |
NDC Properties
NDC Item 00054087949
| NDC 9 | 0054-0879 |
|---|---|
| NDC 10 | 0054-0879-49 |
| NDC Item | 00054087949 |
| Packaging | 1 BOTTLE, GLASS in 1 CARTON (0054-0879-49) / 100 mL in 1 BOTTLE, GLASS |
| ANDA | ANDA216418 |
| COLORTEXT | PINK(Pink to Brown) |
| Color | C48328 __ |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-06-16 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0054-0879 |
NDC Item 00054458249
| NDC 9 | 0054-4582 |
|---|---|
| NDC 10 | 0054-4582-49 |
| NDC Item | 00054458249 |
| Packaging | 1 BOTTLE, GLASS in 1 CARTON (0054-4582-49) / 100 mL in 1 BOTTLE, GLASS |
| ANDA | ANDA216418 |
| COLORTEXT | PINK(Pink to Brown) |
| Color | C48328 __ |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-26 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0054-4582 |
NDC Item 00054087949
| NDC 9 | 0054-0879 |
|---|---|
| NDC 10 | 0054-0879-49 |
| NDC Item | 00054087949 |
| Packaging | 1 BOTTLE, GLASS in 1 CARTON (0054-0879-49) / 100 mL in 1 BOTTLE, GLASS |
| ANDA | ANDA216418 |
| COLORTEXT | PINK(Pink to Brown) |
| Color | C48328 __ |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-06-16 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0054-0879 |
NDC Item 00054458249
| NDC 9 | 0054-4582 |
|---|---|
| NDC 10 | 0054-4582-49 |
| NDC Item | 00054458249 |
| Packaging | 1 BOTTLE, GLASS in 1 CARTON (0054-4582-49) / 100 mL in 1 BOTTLE, GLASS |
| ANDA | ANDA216418 |
| COLORTEXT | PINK(Pink to Brown) |
| Color | C48328 __ |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-26 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0054-4582 |